RxDoctor Payments Data

Timur Sarac, MD

Vascular Surgery · Jacksonville, FLNPI 1457316234

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 45.5% of the total. Reporting peaked in 2023 at $3,940 and has fallen 78.7% since, to $840 in 2025.

$11,647in general payments, 2019–2025

Across 74 payments — averaging $157.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$5K
  • Shape Memory Medical Inc.$2K
  • Convatec Inc.$900
  • Bard Peripheral Vascular, Inc.$854
  • Bolton Medical Inc$518
  • Medtronic$317
  • plus $1K from 8 others
$91,883in research payments, 2019–2025

Across 30 payments — averaging $3062.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endologix LLC$49K
  • W. L. Gore & Associates, Inc.$43K

What the payments were for

  • Consulting fees$9008%
  • Travel & lodging$4,87342%
  • Food & beverage$5,87450%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,647 in reported general payments places this provider in the 65th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida

Medicare billing

Part B allowed, 2024
$8,950
Medicare patients
15
Services billed
28

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →